JAMA oncology
Limitations in Quantitative Harm-Benefit Assessment in Immuno-Oncology-Reply.
James Heyward, Jodi B Segal
Published: 202510.1001/jamaoncol.2025.3792
No abstract available for this study.
James Heyward, Jodi B Segal
No abstract available for this study.